Nuclear Medicine/Radiopharmaceuticals Market share

Worldwide Sales of Nuclear Medicine/Radiopharmaceuticals are predicted to increase at a CAGR of 20.1% during the forecast period – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 23, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Sales of Nuclear Medicine/Radiopharmaceuticals are expected to increase at a CAGR of 20.1% during the forecast period – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 22, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Valuation of Nuclear Medicine/Radiopharmaceuticals is expected to grow at USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 19, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Valuation of Nuclear Medicine/Radiopharmaceuticals is expected to grow at USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 16, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Nuclear Medicine/Radiopharmaceuticals Market is estimated to expand USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 15, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Global Nuclear Medicine/Radiopharmaceuticals Market is anticipated to create a value opportunity of around USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 15, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Valuation of Nuclear Medicine/Radiopharmaceuticals is expected to grow at USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 9, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Nuclear Medicine/Radiopharmaceuticals Market is estimated to expand at a CAGR of 20.1% during the forecast period – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

June 5, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Nuclear Medicine/Radiopharmaceuticals Market is estimated to expand at a CAGR of 20.1% during the forecast period – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 29, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Reach out to us for a consultation.